Article Information
History
- May 28, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Paris J Baptiste, PhD1,8,*,
- Angel YS Wong, PhD1,
- Anna Schultze, PhD1,
- Catherine M Clase, MSc3,7,
- Clémence Leyrat, PhD4,
- Elizabeth Williamson, PhD4,
- Emma Powell, MSc1,
- Johannes FE Mann, MD2,6,
- Marianne Cunnington, PhD5,
- Koon Teo, PhD6,7,
- Shrikant I Bangdiwala, PhD6,7,
- Peggy Gao, MSc6,
- Kevin Wing, PhD1 and
- Laurie Tomlinson, PhD1
- 1Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT
- 2Dept. of Medicine 4, Friedrich Alexander Univ. Erlangen, Germany and KfH Kidney Center, München-Schwabing, Germany
- 3Department of Medicine, McMaster University, Hamilton, Canada
- 4Department of Medical Statistics, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT
- 5Analysis Group Inc., London
- 6Population Health Research Institute, McMaster University, Hamilton, Canada
- 7Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada
- 8Wolfson Institute of Population Health, Faculty of Medicine and Dentistry, Queen Mary University of London, London, E1 2AB
- ↵*Corresponding author: Paris Baptiste, p.baptiste{at}qmul.ac.uk
Posted May 28, 2024.
Cardiorenal effects of dual blockade with Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people with CKD: analysis of routinely collected data with emulation of a reference trial (ONTARGET)
